171 related articles for article (PubMed ID: 16614729)
1. Statins, nitric oxide and neovascularization.
Ma FX; Han ZC
Cardiovasc Drug Rev; 2005; 23(4):281-92. PubMed ID: 16614729
[TBL] [Abstract][Full Text] [Related]
2. Statin therapy and angiogenesis.
Skaletz-Rorowski A; Walsh K
Curr Opin Lipidol; 2003 Dec; 14(6):599-603. PubMed ID: 14624137
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
[TBL] [Abstract][Full Text] [Related]
4. The pro- and antiangiogenic effects of statins.
Skaletz-Rorowski A; Kureishi Y; Shiojima I; Walsh K
Semin Vasc Med; 2004 Nov; 4(4):395-400. PubMed ID: 15861320
[TBL] [Abstract][Full Text] [Related]
5. Rho GTPases, statins, and nitric oxide.
Rikitake Y; Liao JK
Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
[TBL] [Abstract][Full Text] [Related]
6. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
7. Effects of statins on endothelium and endothelial progenitor cell recruitment.
Walter DH; Dimmeler S; Zeiher AM
Semin Vasc Med; 2004 Nov; 4(4):385-93. PubMed ID: 15861319
[TBL] [Abstract][Full Text] [Related]
8. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells.
Walter DH; Zeiher AM; Dimmeler S
Coron Artery Dis; 2004 Aug; 15(5):235-42. PubMed ID: 15238818
[TBL] [Abstract][Full Text] [Related]
9. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
10. Statins activate AMP-activated protein kinase in vitro and in vivo.
Sun W; Lee TS; Zhu M; Gu C; Wang Y; Zhu Y; Shyy JY
Circulation; 2006 Dec; 114(24):2655-62. PubMed ID: 17116771
[TBL] [Abstract][Full Text] [Related]
11. Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.
Chiang KH; Cheng WL; Shih CM; Lin YW; Tsao NW; Kao YT; Lin CT; Wu SC; Huang CY; Lin FY
PLoS One; 2015; 10(8):e0136405. PubMed ID: 26309120
[TBL] [Abstract][Full Text] [Related]
12. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
[TBL] [Abstract][Full Text] [Related]
13. Double-edged role of statins in angiogenesis signaling.
Urbich C; Dernbach E; Zeiher AM; Dimmeler S
Circ Res; 2002 Apr; 90(6):737-44. PubMed ID: 11934843
[TBL] [Abstract][Full Text] [Related]
14. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Kureishi Y; Luo Z; Shiojima I; Bialik A; Fulton D; Lefer DJ; Sessa WC; Walsh K
Nat Med; 2000 Sep; 6(9):1004-10. PubMed ID: 10973320
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide.
Ma S; Ma CC
Vascul Pharmacol; 2014 Nov; 63(2):63-70. PubMed ID: 25139660
[TBL] [Abstract][Full Text] [Related]
16. [Pleiotropic effects of statins on endothelium and signaling mechanisms].
Shiota M; Izumi Y; Nakao T; Iwao H
Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):161-6. PubMed ID: 16971779
[No Abstract] [Full Text] [Related]
17. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.
Urbich C; Dimmeler S
Kidney Int; 2005 May; 67(5):1672-6. PubMed ID: 15840010
[TBL] [Abstract][Full Text] [Related]
18. Advances in the molecular mechanisms of statins in regulating endothelial nitric oxide bioavailability: Interlocking biology between eNOS activity and L-arginine metabolism.
Chen WH; Chen CH; Hsu MC; Chang RW; Wang CH; Lee TS
Biomed Pharmacother; 2024 Feb; 171():116192. PubMed ID: 38262153
[TBL] [Abstract][Full Text] [Related]
19. The role of endothelial progenitor cells and statins in endothelial function: a review.
Gómez-Cerezo JF; Pagán-Muñoz B; López-Rodríguez M; Estébanez-Muñoz M; Barbado-Hernández FJ
Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):265-72. PubMed ID: 17979688
[TBL] [Abstract][Full Text] [Related]
20. Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis.
Sata M; Nishimatsu H; Osuga J; Tanaka K; Ishizaka N; Ishibashi S; Hirata Y; Nagai R
Hypertension; 2004 Jun; 43(6):1214-20. PubMed ID: 15166180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
